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It has been proposed that long-term memory (LTM) persistence requires a late protein
synthesis-dependent phase, even many hours after memory acquisition. Brain-derived neu-
rotrophic factor (BDNF) is an essential protein synthesis product that has emerged as one
of the most potent molecular mediators for long-term synaptic plasticity. Studies in the rat
hippocampus have been shown that BDNF is capable to rescue the late-phase of long-term
potentiation as well as the hippocampus-related LTM when protein synthesis was inhibited.
Our previous studies on the insular cortex (IC), a region of the temporal cortex implicated
in the acquisition and storage of conditioned taste aversion (CTA), have demonstrated that
intracortical delivery of BDNF reverses the deﬁcit in CTA memory caused by the inhibition
of IC protein synthesis due to anisomycin administration during early acquisition. In this
work, we ﬁrst analyze whether CTA memory storage is protein synthesis-dependent in
different time windows. We observed that CTA memory become sensible to protein syn-
thesis inhibition 5 and 7 h after acquisition. Then, we explore the effect of BDNF delivery
(2μg/2μl per side) in the IC during those late protein synthesis-dependent phases. Our
results show that BDNF reverses the CTA memory deﬁcit produced by protein synthe-
sis inhibition in both phases. These ﬁndings support the notion that recurrent rounds of
consolidation-like events take place in the neocortex for maintenance of CTA memory trace
and that BDNF is an essential component of these processes.
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INTRODUCTION
Is now considered that memory can be divided into at least
two stages: a protein synthesis-independent phase (short-term
memory; STM), lasting minutes to hours and a protein synthesis-
dependent phase (long-termmemory; LTM), lasting several hours,
days, or longer (Bailey et al., 2004; Medina et al., 2008). The
process of developing stable memory is referred as consolidation.
However, a single molecular cascade consisting of receptor activa-
tion, changes in protein phosphorylation, and a transient change
in protein production, may be insufﬁcient for the persistence of
LTM (Wittenberg and Tsien, 2002; Tsien, 2006). Instead, it has
been demonstrated the existence of a delayed protein synthesis-
dependent phase for behavioral memory persistence, even several
hours after memory acquisition (Grecksch and Matthies, 1980;
Freeman et al., 1995; Quevedo et al., 1999; Igaz et al., 2002; Bekin-
schtein et al., 2007; Romero-Granados et al., 2010), showing that
speciﬁc rounds of consolidation-like events take place for the
maintenance of the memory trace.
Brain-derived neurotrophic factor (BDNF) has been consid-
ered as a protein synthesis product essential for the expression
and persistence of long-term synaptic plasticity in the adult brain
(Pang et al., 2004; Bekinschtein et al., 2008a,b; Moguel-Gonzalez
et al., 2008). Alonso et al. (2002) showed that hippocampal BDNF
is required for the formation of both short- andLTMand is contin-
uously activated, in a time-dependent manner after consolidation
for persistence of long-term hippocampal memory (Alonso et al.,
2002). Previous studies in the rat hippocampus have demonstrated
that application of BDNF is sufﬁcient to rescue the late-phase of
long-term potentiation (LTP) after protein synthesis inhibition
(Pang et al., 2004). Recently, it has been demonstrated that 12 h
after acquisition of a one-trial associative learning task, there is
a novel protein synthesis and BDNF-dependent phase in the rat
hippocampus that is critical for the persistence of LTM storage
(Bekinschtein et al., 2007, 2008b). BDNF and its high afﬁnity
receptor tyrosine kinase receptor B (TrkB) are also abundantly
expressed in the neocortex (Yan et al., 1997).
The insular cortex (IC) is a region of the temporal cortex in
the rat that has been implicated in the acquisition and storage of
different aversive motivated learning tasks like conditioned taste
aversion (CTA). CTA is a very robust and widely used model for
the study of learning and memory processes in which an animal
acquires aversion to a novel taste when it is followed by diges-
tive malaise (Bermudez-Rattoni, 2004; Bernstein and Koh, 2007;
Bertrand et al., 2009). Our previous studies demonstrated that
acutemicroinfusionof BDNF in anesthetized adult rats 24 hbefore
CTA training enhances the retention of this task (Castillo et al.,
2006). Moreover, it has been observed that protein translation
inhibition impairs CTA consolidation but not acquisition (Rosen-
blum et al., 1993; Serova et al., 1996; Berman and Dudai, 2001;
Moguel-Gonzalez et al., 2008) and we recently reported that acute
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intracortical delivery of BDNF reverses the deﬁcit in CTAmemory,
caused by inhibition of IC protein synthesis due to anisomycin
administration (Moguel-Gonzalez et al., 2008). These evidences
suggest that BDNF is an essential protein synthesis product for
the establishment of the CTA–LTM. However, the requirement of
protein synthesis and BDNF in different time windows after the
acquisition of CTA has not been explored so far.
In the present study, we explore the protein synthesis-
dependence of CTA–LTM in different time windows after acquisi-
tion. Then,we analyze the effect of BDNF delivery in the IC during
those late protein synthesis-dependent phases.
MATERIALS AND METHODS
ANIMALS
A total of 104 male Wistar rats weighing 345–380 g were prepared
for this experiment. Methods were carried out using adequate
measures to minimize pain or discomfort, as outlined in the NIH
Guide for the Care and Use of Laboratory Animals. They were
housed individually under 12/12-h light-dark cycle, with food and
water ad libitum (except where indicated) and an average room
temperature of 22˚C.
CANNULAE IMPLANTATION
Animals were implanted bilaterally with 23-gage stainless steel
cannulae under anesthesia (Pentobarbital, 50 ml/kg i.p.) using a
previously described procedure (Moguel-Gonzalez et al., 2008).
The tips of the guide cannulae were aimed to 2 mm above the IC
(Castillo et al., 2006). Microinjections were delivered through 30-
gage dental needles as microinjectors that extended 2 mm below
the previously implanted guide cannulae (reaching the IC area).
Dental needle microinjectors were attached by polyethylene tub-
ing to a 10-μl Hamilton syringe driven by a microinfusion pump
(Cole Parmer Co.). After surgery animals were allowed to recover
for 7 days. All groups were histologically analyzed in order to verify
the injector tip location.
CTA TRAINING
After a 1-week recovery period, animals were introduced in the
CTA training, as previously described (Moguel-Gonzalez et al.,
2008; Rodriguez-Duran et al., 2011). Brieﬂy, rats were deprived of
water for 24 h and then habituated to drink water from a single
graduated cylinder twice a day, during 10 min trials for 3 days. On
the acquisition day, water was substituted for saccharin solution
0.1% (Sigma, St. Louis, MO, USA), and 10 min later, the animals
received 7.5 ml/kg i.p. of a 0.15-M solution of LiCl, which induces
digestive malaise. After three more days of baseline consumption,
waterwas substitutednewly by a 0.1% saccharin solution to test the
aversion. The reduction of saccharin consumption with respect to
baseline intake was used as a measure of strength of aversion.
EXPERIMENTAL DESIGN
It has been demonstrated that protein synthesis inhibition in the
IC prevents CTA consolidation (Rosenblum et al., 1993; Berman
and Dudai, 2001; Moguel-Gonzalez et al., 2008; Rodriguez-Duran
et al., 2011). In order to explore the protein synthesis-dependence
of CTA–LTM in different time windows after the acquisition ses-
sion, intracortical microinfusions of anisomycin at a concentra-
tion that has been shown to act for 90 min with a 90% of protein
synthesis inhibition (100μg/μl per side, Sigma, St. Louis, MO,
USA; Rosenblum et al., 1993; Moguel-Gonzalez et al., 2008) were
applied at 3 (Ani3,n = 10),5 (Ani5,n = 8),7 (Ani7,n = 10), and12
(Ani12, n = 8) hours after CTA acquisition in the IC (Figure 1B).
It has been observed that BDNF reverses the deﬁcit in CTA
memory caused by inhibition of IC protein synthesis due to ani-
somycin administration (Moguel-Gonzalez et al., 2008). In order
to analyze if BDNF delivery is capable of revert the deﬁcit in CTA
memory during those time windows in which memory is sensi-
tive to protein synthesis inhibition, intracortical microinfusions
of BDNF (2 μg/2 μl per side, Alomone Labs, Jerusalem; Escobar
et al., 2003; Castillo et al., 2006;Moguel-Gonzalez et al., 2008) were
applied in the IC immediately after the anisomycin administra-
tion at 5 (AniBDNF5, n = 8) or 7 (AniBDNF7, n = 9) hours after
CTA acquisition. In a similar manner, intracortical microinfusions
of phosphate buffer solution (PBS) were applied immediately
after the anisomycin administration at 5 (AniPBS5, n = 10) or
7 (AniPBS7, n = 9) hours after CTA acquisition, as BDNF vehi-
cle. Artiﬁcial cerebrospinal ﬂuid (ACSF, 1 μl/min) microinfusions
were applied at 5 (ACSF5, n = 12) or 7 (ACSF7, n = 10) hours
after CTA acquisition, as anisomycin vehicle. An additional group
(CON, n = 10) was trained in CTA without any pharmacological
treatment (Figure 1C). Upon completing the behavioral experi-
ments, cannulated animals were histologically analyzed in order
to verify the injector tip location.
RESULTS
HISTOLOGY
Histological examinations revealed that injectors were placed in
the IC in all the groups (Figure 1A). Two animals with unclear
cannulae placements were discarded; one of them was from the
AniPBS7 group and the other from the CON group.
CTA BASELINE WATER CONSUMPTION
No signiﬁcant differences were found among groups neither in the
baseline water intake nor during the ﬁrst presentation of the con-
ditioned stimulus. The average baseline means (± SEM) of water
intake were (in ml): 13.56 ± 0.050, 13.33± 0.31, 13.78± 0.49,
13.± 0.60, 13.33± 0.46, 14.49± 0.60, 15.36± 0.34, 11.68± 0.72,
15.77± 0.39, 15.20± 0.51, and 15.98± 0.58 for the Ani3, Ani5,
Ani7, Ani12, AniBDNF5, AniPBS5, ACSF5, AniBDNF7, AniPBS7,
ACSF7, and CON groups, respectively.
CTA–LTM IS SENSITIVE TO PROTEIN SYNTHESIS INHIBITION AT 5 AND
7H AFTER THE ACQUISITION OF THIS TASK
As shown in Figure 2, intracortical anisomycin microinfusions
prevent the persistence of CTA memory when administered 5 and
7, but not 3 or 12 h after the acquisition session. ANOVA analy-
sis for saccharin consumption during the aversion test revealed
signiﬁcant differences among groups (F4,41 = 88.63, p< 0.001).
Post hoc analysis with Fisher’s test showed that the Ani5 and
Ani7 groups had a signiﬁcant impairment in CTA memory when
compared with Ani3, Ani12, and CON groups. The mean of
saccharin consumption during the acquisition session for the
Ani3, Ani5, Ani7, Ani12, and CON groups were 13.56± 1.05,
11.62± 3.00, 12.8± 1.87, 11.62± 1.63, and 15.46± 2.65, respec-
tively. These results reveal that CTA–LTM becomes dependent on
protein synthesis 5 and 7 h after memory acquisition.
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FIGURE 1 | Schematic representation of the experimental
procedure. (A) Schematic diagram of the guide cannulae and
microinjectors placement in a coronal plane. (B) Diagram of the
experimental procedure for the analysis of late protein
synthesis-dependent phases in CTA–LTM. (C) Diagram of the
experimental procedure for the exploration of the BDNF effect on CTA
deﬁcit due to protein synthesis inhibition. Abbreviations: IC, insular
cortex; ACQ, acquisition; ACSF, artiﬁcial cerebrospinal ﬂuid; Ani,
anisomycin; BDNF, Brain-derived neurotrophic factor; PBS, phosphate
buffer solution. Scale bar: 1mm.
BDNF REVERSES THE DEFICIT IN CTA–LTM CAUSED BY PROTEIN
SYNTHESIS INHIBITION AT 5 AND 7H AFTER THE ACQUISITION OF THIS
TASK
Our results show that intracortical delivery of BDNF in the IC
reverses the deﬁcit in CTA memory caused by the inhibition of
IC protein synthesis at 5 and 7 h after the acquisition of this
task (Figure 3). ANOVA analysis for saccharin consumption dur-
ing the aversion test revealed signiﬁcant differences among those
groups that were infused 5 h (F3,36 = 87.39, p< 0.001; Figure 3)
as well as those groups that were infused 7 h after the acquisi-
tion session (F3,34 = 102.09, p< 0.001, Figure 3). Post hoc analy-
sis with Fisher’s test showed that AniBDNF5 and AniBDNF7
groups had a signiﬁcant improvement in CTA memory per-
sistence as indicated by the decrease of saccharin consump-
tion when compared with the AniPBS5 and AniPBS7 groups.
No signiﬁcant differences were observed among the AniBDNF5,
AniBDNF7, ACSF5, ACSF7, and CON groups. The mean of
saccharin consumption during the acquisition session for the
AniBDNF5, AniPBS5, ACSF5, AniBDNF7, AniPBS7, and ACSF7
groupswere 11.55± 1.33, 13.00± 1.49, 13.83± 1.27, 10.88± 1.83,
14.22± 1.39, and 15.20± 1.62, respectively. These results demon-
strate that intracortical delivery of BDNF reverses the deﬁcit in
CTA memory maintenance caused by inhibition of IC protein
synthesis even 5 and 7 h after memory acquisition.
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FIGURE 2 | Conditioned taste aversion-LTM is sensitive to protein
synthesis inhibition at 5 and 7h after the acquisition of this task. Acute
intracortical microinfusion of anisomycin (100μg per side) carried out 5
(Ani5) or 7 (Ani7) but not 3 (Ani3) or 12 (Ani12) hours after memory
acquisition impairs CTA memory. An additional control group (CON) remains
intact during the whole procedure. **p<0.001.
FIGURE 3 | Brain-derived neurotrophic factor (BDNF) reverses the
deficit in CTA–LTM caused by protein synthesis inhibition at 5 and 7h
after the acquisition of this task. Acute intracortical microinfusion of
BDNF (2μg per side) immediately after anisomycin administration (100μg
per side) reverses the impairment in CTA memory. Animals received
intracortical infusion of artiﬁcial cerebrospinal ﬂuid (ACSF5 and ACSF7),
anisomycin plus BDNF (AniBDNF5 and AniBDNF7) or anisomycin plus
phosphate buffer solution (AniPBS5 and AniPBS7). An additional control
group (CON) remains intact during the whole procedure. **p<0.001.
DISCUSSION
A great body of evidence shows that LTM trace is sensitive to
protein synthesis inhibition during the ﬁrst hours after memory
acquisition (McGaugh, 1966, 2000; Davis and Squire, 1984; Kan-
del, 2001; Barrientos et al., 2002; Dudai, 2002). However, it has
been proposed that a single molecular cascade triggered during
learning might not be sufﬁcient to account for the persistence of
memory in the mammalian brain (Wittenberg and Tsien, 2002),
raising the notion that recurrent rounds of consolidation-like
events are required for the persistence of LTM in the hippocampus
(Bekinschtein et al., 2007). Several studies have been demonstrated
that protein synthesis is also critical for memory persistence at
least in two time periods: around the time of and several hours
after training (Quevedo et al., 1999; Igaz et al., 2002; Bekinschtein
et al., 2008b; Romero-Granados et al., 2010). These late pro-
tein synthesis-dependent periods have been reported in the rat
hippocampus 4 h after recognition memory formation (Romero-
Granados et al., 2010) as well as 12 h after acquisition of a one-trial
IA task (Bekinschtein et al., 2007, 2008b).
The present results show that the persistence of the CTA mem-
ory requires a late protein synthesis-dependent phase 5 and 7 h
but not 3 or 12 h after memory acquisition in the IC, a neocortical
area where certain forms of aversive memory are likely to reside
(Bermudez-Rattoni, 2004; Moguel-Gonzalez et al., 2008). These
results suggest that the reactivation of a cascade of molecular and
cellular events takes place in the IC for the maintenance of CTA
memory trace.
Brain-derived neurotrophic factor is now considered as an
essential protein synthesis product for the establishment of
synaptic plasticity (Minichiello, 2009; Bekinschtein et al., 2010;
Musumeci and Minichiello, 2011). Our previous studies show that
acute intrahippocampal microinfusion of BDNF induces LTP in
the hippocampal DG-CA3 (mossy ﬁber) projection. This poten-
tiation was accompanied by a presynaptic structural long-lasting
reorganization and a change in the possibility to induce subse-
quent LTP at the mossy ﬁber pathway (Gomez-Palacio-Schjetnan
and Escobar, 2008; Schjetnan and Escobar, 2010). In addition, it
has been shown that BDNF induces long-term modiﬁcations that
underlie the late-phase of LTP in the CA1 area of the hippocampus
(Pang et al., 2004). Moreover, intrahippocampal microinfusion of
BDNF induces memory persistence by itself transforming a non-
lasting LTM trace into a persistent one (Bekinschtein et al., 2008b).
In the other hand, our studies in the IC have shown that exoge-
nous application of BDNF in the IC enhances synaptic efﬁcacy
in the basolateral amygdaloid nucleus–IC projection and mod-
iﬁes the retention of CTA (Escobar et al., 2003; Castillo et al.,
2006; Castillo and Escobar, 2011) and recently we showed that
the deﬁcit in CTA memory caused by the inhibition of protein
synthesis in the IC, during the acquisition session is reversed by
an acute intracortical delivery of BDNF (Moguel-Gonzalez et al.,
2008).
In the present work we show that acute intracortical delivery of
BDNF reverses the deﬁcit inCTAmemory caused by the inhibition
of IC protein synthesis due to anisomycin administration 5 and
7 h after memory acquisition. BDNF is essential for the consoli-
dation of CTA memory early after acquisition (Moguel-Gonzalez
et al., 2008) and the present data reveals that this neurotrophin
is also required for CTA–LTM persistence even several hours after
the acquisition session.
In the same order of ideas, it has been demonstrated that BDNF
endogenous expression is modulated in different time windows
during the formation of LTM (Ou et al., 2010; Ma et al., 2011).
In a recent study Ou et al. (2010) showed that fear conditioning
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training triggers two peaks of BDNF expression in the amygdala,
at 1 and 12 h after conditioning. In the hippocampus, IA memory
presents a BDNF-dependent phase 12 h after training and BDNF
infusion into this time window transform a non-lasting LTM trace
into a persistent one (Bekinschtein et al., 2008b). These evidences
suggest that an endogenous increase in BDNF production is nec-
essary for the maintenance of LTM. In a similar manner, a recent
study of Ma et al. (2011) shows the speciﬁc regional involvement
of BDNF secretion and synthesis in the CTA–LTM. They reported
that the CTA training induces an increase in BDNF levels at the
IC. This increase starts at 2 h, peaked at 6 and returned to baseline
at 8 h after CTA acquisition (Ma et al., 2011). Accordingly, in the
present work, we observed that intracortical delivery of BDNF is
sufﬁcient to reverse the LTM impairment produced by anisomycin
microinfusion, within the time of BDNF expression presented by
Ma et al., 2011; 5 and 7 h after the CTA acquisition), suggesting
that a late-phase of endogenous release of BDNF is required for
the maintenance of CTA–LTM.
Release of BDNF initiates a cascade of molecular mechanisms
related with activity-dependent synaptic changes (Minichiello,
2009;Musumeci andMinichiello,2011). This neurotrophin and its
high afﬁnity receptor TrkB trigger a molecular cascade of proteins,
as the mitogen-activated protein kinase (MAPK), the phospho-
lipase C-gamma (PLC-gamma) and the phosphatidylinositol-3
kinase (PI-3K) pathways (Minichiello et al., 2002). Through
these pathways, BDNF regulates the activity-dependent changes
in synaptic properties related with the maintenance of the LTM of
several learning tasks (Yamada and Nabeshima, 2003). For exam-
ple, training in the IA task requires a late BDNF-dependent phase
in the hippocampus 12 h after training (Bekinschtein et al., 2007).
In addition, it has been observed a late increase in extracellu-
lar signal-regulated kinases (ERK) phosphorylation levels in the
hippocampus 12 h after IA training, and intrahippocampal infu-
sion of the MAPK kinase (MEK) inhibitor, U0126, resulted in a
deﬁcit in LTM retention (Bekinschtein et al., 2008b). Our previous
studies on the IC showed that microinfusion of BDNF previ-
ous to CTA training modiﬁes the retention of this task, through
the activation of MAPK and PI-3K at the IC (Castillo et al.,
2006; Castillo and Escobar, 2011). The mentioned molecular cas-
cades converge in the activation of transcription factors, such as
cyclic adenosine monophosphate response element-binding pro-
tein (CREB), which induce gene expression (e.g., Arc and Zif
286) and thereby LTM-related synaptic changes (Minichiello et al.,
2002; Minichiello, 2009).
Although the molecular mechanisms triggered by BDNF
underlying the persistence of behavioral memories remains
unclear, it has been observed that BDNF enhances the expres-
sion of the protein kinase M ζ (PKMζ), an atypical isoform of the
protein kinases C (PKC) which plays a crucial role in the persis-
tence of LTM in several behavioral tasks, including CTA (Shema
et al., 2007, 2009, 2011; Gamiz and Gallo, 2011; Sacktor, 2011).
The local synthesis of BDNF and PKMζ are required for the main-
tenance of certain forms of LTP (Sajikumar and Korte, 2011) and
recently, Mei et al. (2011) demonstrated that BDNF is capable to
sustain the late-phase of LTP through PKMζ in a protein synthesis-
independent manner, providing a strong mechanistic link between
BDNF and PKMζ in the persistence of synaptic plasticity.
In summary, the present results show that CTA memory
becomes sensible to protein synthesis inhibition 5 and 7 h after
memory acquisition, revealing that new protein synthesis is
required for the maintenance of CTA–LTM even hours after acqui-
sition. Furthermore, BDNF reverses the CTA memory deﬁcit
produced by protein synthesis inhibition during both late-phases,
showing that BDNF is an essential protein product for the persis-
tence of CTA in different post-acquisition time windows. These
evidences suggest that a new round of consolidation-like events
take place in the IC for the maintenance of the CTA memory trace
and stress the role of BDNF as a key protein which promotes the
persistence of LTM in the neocortex.
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